Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil
| Ano de defesa: | 2013 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | , |
| Tipo de documento: | Dissertação |
| Tipo de acesso: | Acesso aberto |
| Idioma: | por |
| Instituição de defesa: |
Universidade Federal de Alfenas
|
| Programa de Pós-Graduação: |
Programa de Pós-Graduação em Química
|
| Departamento: |
Instituto de Química
|
| País: |
Brasil
|
| Palavras-chave em Português: | |
| Área do conhecimento CNPq: | |
| Link de acesso: | https://repositorio.unifal-mg.edu.br/handle/123456789/377 |
Resumo: | Alzheimer disease (AD) is a neurodegenerative disease clinically characterized by a progressive memory loss, which results in psychical and motor disfunction (FARRAN, JAMES, et al., 2011). Due to the large worldwide number of people with this disease, it is a challenge to science and public health. Therefore, projects aiming the disease symptomatic treatment and a patient progressive improvement are essential. Previous studies at the Laboratory of Phytochemistry and Medicinal Chemistry - LFQM -in Federal University of Alfenas - UNIFAL-MG, led to the discovery of the substance LFQM-18 (6 Figure 9) (new substance that presented a preliminary activity of acetylcholinesterase inhibitory), which was a prototype on the genesis of new compounds capable of acting as therapeutic agents in neurodegenerative diseases, especially Alzheimer's disease (AD). An analogous series of LFQM-18 was proposed and 10 new intermediary substances were synthesized and studied, validating the synthetic route for obtaining them. It was obtained, as a final product, acylhydrazone 17, evaluated preliminarily through Marston's test, which has indicated a low activity for the compound. Additional studies are ongoing to confirm the AChE inhibitory activity for compound 17. |
| id |
UNIFAL_c5ee075ea29f7b8909cfb53ae59b96f8 |
|---|---|
| oai_identifier_str |
oai:repositorio.unifal-mg.edu.br:123456789/377 |
| network_acronym_str |
UNIFAL |
| network_name_str |
Repositório Institucional da Universidade Federal de Alfenas - RiUnifal |
| repository_id_str |
|
| spelling |
Simões, Maria Cecília Rodrigueshttp://lattes.cnpq.br/1381066386437549Dias, Danielle FerreiraViana, Gustavo Henrique RibeiroViegas Júnior, Cláudiohttp://lattes.cnpq.br/85171953326079192015-06-12T22:44:37Z2013-02-01SIMÕES, Maria Cecília Rodrigues. Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil. 2013. 152 f. Dissertação (Mestrado em Química) - Universidade Federal de Alfenas, Alfenas, MG, 2013.https://repositorio.unifal-mg.edu.br/handle/123456789/377Alzheimer disease (AD) is a neurodegenerative disease clinically characterized by a progressive memory loss, which results in psychical and motor disfunction (FARRAN, JAMES, et al., 2011). Due to the large worldwide number of people with this disease, it is a challenge to science and public health. Therefore, projects aiming the disease symptomatic treatment and a patient progressive improvement are essential. Previous studies at the Laboratory of Phytochemistry and Medicinal Chemistry - LFQM -in Federal University of Alfenas - UNIFAL-MG, led to the discovery of the substance LFQM-18 (6 Figure 9) (new substance that presented a preliminary activity of acetylcholinesterase inhibitory), which was a prototype on the genesis of new compounds capable of acting as therapeutic agents in neurodegenerative diseases, especially Alzheimer's disease (AD). An analogous series of LFQM-18 was proposed and 10 new intermediary substances were synthesized and studied, validating the synthetic route for obtaining them. It was obtained, as a final product, acylhydrazone 17, evaluated preliminarily through Marston's test, which has indicated a low activity for the compound. Additional studies are ongoing to confirm the AChE inhibitory activity for compound 17.A Doença de Alzheimer (DA) é uma doença neurodegenerativa caracterizada clinicamente por uma perda progressiva de memória, que acarreta em disfunções psíquicas e motoras (FARRAN, JAMES, et al., 2011). Devido ao grande número de pessoas acometidas pela doença em todo o mundo, a mesma constitui um desafio a própria ciência e à saúde pública, e assim, projetos que visem o tratamento sintomático da doença e uma melhora progressiva do paciente são essenciais. Estudos anteriores no Laboratório de Fitoquímica e Química Medicinal – LFQM da Universidade Federal de Alfenas –UNIFAL-MG, levaram a descoberta da substância LFQM-18 (6 Figura 9) (substância inédita que apresentou uma atividade preliminar inibitória de acetilcolinesterase), que foi um protótipo na gênese de novos compostos capazes de atuar como agentes terapêuticos em doenças neurodegenerativas especialmente a Doença de Alzheimer (DA). Uma série análoga a LFQM-18 foi proposta e 10 novas substâncias intermediárias foram sintetizadas e estudadas, validando a rota sintética de obtenção das mesmas. Obteve-se como produto final a acilidrazona 17, avaliada preliminarmente através do teste de Marston, que indicou uma baixa atividade para o composto. Estudos adicionais estão em andamento para confirmar a atividade inibitória de AChE para o composto 17.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESapplication/pdfporUniversidade Federal de AlfenasPrograma de Pós-Graduação em QuímicaUNIFAL-MGBrasilInstituto de Químicainfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/4.0/Doença de AlzheimerInibidores de ColinesteraseFármacos do Sistema Nervoso CentralQUIMICA::QUIMICA ORGANICAEstudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezilinfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/publishedVersion1328253078826782306600600600-81940697172828021542075167498588264571reponame:Repositório Institucional da Universidade Federal de Alfenas - RiUnifalinstname:Universidade Federal de Alfenas (UNIFAL)instacron:UNIFALSimões, Maria Cecília RodriguesLICENSElicense.txtlicense.txttext/plain; charset=utf-81987https://repositorio.unifal-mg.edu.br/bitstreams/7915c3d5-777f-4f04-a00e-ba574359341f/download31555718c4fc75849dd08f27935d4f6bMD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849https://repositorio.unifal-mg.edu.br/bitstreams/34fdd0c7-0236-4f08-9a71-69d0c8bbf8c4/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80https://repositorio.unifal-mg.edu.br/bitstreams/ad1080df-3be5-4934-a2e0-9c2790a71eec/downloadd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80https://repositorio.unifal-mg.edu.br/bitstreams/8ffe6686-f495-41a9-a11b-9ed9567d15f8/downloadd41d8cd98f00b204e9800998ecf8427eMD54ORIGINALDissertação de Maria Cecília Rodrigues Simões.pdfDissertação de Maria Cecília Rodrigues Simões.pdfapplication/pdf4572356https://repositorio.unifal-mg.edu.br/bitstreams/3005d75f-6ece-48fa-85fe-e30187e8018e/download2ce3803d1a86294b6eb6b86aaf5f5abfMD55TEXTDissertação de Maria Cecília Rodrigues Simões.pdf.txtDissertação de Maria Cecília Rodrigues Simões.pdf.txtExtracted texttext/plain103270https://repositorio.unifal-mg.edu.br/bitstreams/0d798e0b-6e79-463e-9328-48071fb05b34/download0e0415e41f9edb5fa9f148b69fbdf588MD510THUMBNAILDissertação de Maria Cecília Rodrigues Simões.pdf.jpgDissertação de Maria Cecília Rodrigues Simões.pdf.jpgGenerated Thumbnailimage/jpeg2929https://repositorio.unifal-mg.edu.br/bitstreams/57e33764-3c45-4ad7-bfa6-01de496d2df8/download1aad5737520e855c111c4649594ab070MD59123456789/3772026-01-07 14:25:27.777http://creativecommons.org/licenses/by-nc-nd/4.0/open.accessoai:repositorio.unifal-mg.edu.br:123456789/377https://repositorio.unifal-mg.edu.brRepositório InstitucionalPUBhttps://bdtd.unifal-mg.edu.br:8443/oai/requestrepositorio@unifal-mg.edu.bropendoar:2026-01-07T17:25:27Repositório Institucional da Universidade Federal de Alfenas - RiUnifal - Universidade Federal de Alfenas (UNIFAL)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 |
| dc.title.pt-BR.fl_str_mv |
Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil |
| title |
Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil |
| spellingShingle |
Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil Simões, Maria Cecília Rodrigues Doença de Alzheimer Inibidores de Colinesterase Fármacos do Sistema Nervoso Central QUIMICA::QUIMICA ORGANICA |
| title_short |
Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil |
| title_full |
Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil |
| title_fullStr |
Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil |
| title_full_unstemmed |
Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil |
| title_sort |
Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil |
| author |
Simões, Maria Cecília Rodrigues |
| author_facet |
Simões, Maria Cecília Rodrigues |
| author_role |
author |
| dc.contributor.author.fl_str_mv |
Simões, Maria Cecília Rodrigues |
| dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/1381066386437549 |
| dc.contributor.referee1.fl_str_mv |
Dias, Danielle Ferreira |
| dc.contributor.referee2.fl_str_mv |
Viana, Gustavo Henrique Ribeiro |
| dc.contributor.advisor1.fl_str_mv |
Viegas Júnior, Cláudio |
| dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/8517195332607919 |
| contributor_str_mv |
Dias, Danielle Ferreira Viana, Gustavo Henrique Ribeiro Viegas Júnior, Cláudio |
| dc.subject.por.fl_str_mv |
Doença de Alzheimer Inibidores de Colinesterase Fármacos do Sistema Nervoso Central |
| topic |
Doença de Alzheimer Inibidores de Colinesterase Fármacos do Sistema Nervoso Central QUIMICA::QUIMICA ORGANICA |
| dc.subject.cnpq.fl_str_mv |
QUIMICA::QUIMICA ORGANICA |
| description |
Alzheimer disease (AD) is a neurodegenerative disease clinically characterized by a progressive memory loss, which results in psychical and motor disfunction (FARRAN, JAMES, et al., 2011). Due to the large worldwide number of people with this disease, it is a challenge to science and public health. Therefore, projects aiming the disease symptomatic treatment and a patient progressive improvement are essential. Previous studies at the Laboratory of Phytochemistry and Medicinal Chemistry - LFQM -in Federal University of Alfenas - UNIFAL-MG, led to the discovery of the substance LFQM-18 (6 Figure 9) (new substance that presented a preliminary activity of acetylcholinesterase inhibitory), which was a prototype on the genesis of new compounds capable of acting as therapeutic agents in neurodegenerative diseases, especially Alzheimer's disease (AD). An analogous series of LFQM-18 was proposed and 10 new intermediary substances were synthesized and studied, validating the synthetic route for obtaining them. It was obtained, as a final product, acylhydrazone 17, evaluated preliminarily through Marston's test, which has indicated a low activity for the compound. Additional studies are ongoing to confirm the AChE inhibitory activity for compound 17. |
| publishDate |
2013 |
| dc.date.issued.fl_str_mv |
2013-02-01 |
| dc.date.accessioned.fl_str_mv |
2015-06-12T22:44:37Z |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
masterThesis |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
SIMÕES, Maria Cecília Rodrigues. Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil. 2013. 152 f. Dissertação (Mestrado em Química) - Universidade Federal de Alfenas, Alfenas, MG, 2013. |
| dc.identifier.uri.fl_str_mv |
https://repositorio.unifal-mg.edu.br/handle/123456789/377 |
| identifier_str_mv |
SIMÕES, Maria Cecília Rodrigues. Estudos visando a síntese e avaliação farmacológica de novos protótipos à fármacos inibidores de acetilcolinesterase planejados a partir do Donepezil. 2013. 152 f. Dissertação (Mestrado em Química) - Universidade Federal de Alfenas, Alfenas, MG, 2013. |
| url |
https://repositorio.unifal-mg.edu.br/handle/123456789/377 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.relation.department.fl_str_mv |
1328253078826782306 |
| dc.relation.confidence.fl_str_mv |
600 600 600 |
| dc.relation.cnpq.fl_str_mv |
-8194069717282802154 |
| dc.relation.sponsorship.fl_str_mv |
2075167498588264571 |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidade Federal de Alfenas |
| dc.publisher.program.fl_str_mv |
Programa de Pós-Graduação em Química |
| dc.publisher.initials.fl_str_mv |
UNIFAL-MG |
| dc.publisher.country.fl_str_mv |
Brasil |
| dc.publisher.department.fl_str_mv |
Instituto de Química |
| publisher.none.fl_str_mv |
Universidade Federal de Alfenas |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da Universidade Federal de Alfenas - RiUnifal instname:Universidade Federal de Alfenas (UNIFAL) instacron:UNIFAL |
| instname_str |
Universidade Federal de Alfenas (UNIFAL) |
| instacron_str |
UNIFAL |
| institution |
UNIFAL |
| reponame_str |
Repositório Institucional da Universidade Federal de Alfenas - RiUnifal |
| collection |
Repositório Institucional da Universidade Federal de Alfenas - RiUnifal |
| bitstream.url.fl_str_mv |
https://repositorio.unifal-mg.edu.br/bitstreams/7915c3d5-777f-4f04-a00e-ba574359341f/download https://repositorio.unifal-mg.edu.br/bitstreams/34fdd0c7-0236-4f08-9a71-69d0c8bbf8c4/download https://repositorio.unifal-mg.edu.br/bitstreams/ad1080df-3be5-4934-a2e0-9c2790a71eec/download https://repositorio.unifal-mg.edu.br/bitstreams/8ffe6686-f495-41a9-a11b-9ed9567d15f8/download https://repositorio.unifal-mg.edu.br/bitstreams/3005d75f-6ece-48fa-85fe-e30187e8018e/download https://repositorio.unifal-mg.edu.br/bitstreams/0d798e0b-6e79-463e-9328-48071fb05b34/download https://repositorio.unifal-mg.edu.br/bitstreams/57e33764-3c45-4ad7-bfa6-01de496d2df8/download |
| bitstream.checksum.fl_str_mv |
31555718c4fc75849dd08f27935d4f6b 4afdbb8c545fd630ea7db775da747b2f d41d8cd98f00b204e9800998ecf8427e d41d8cd98f00b204e9800998ecf8427e 2ce3803d1a86294b6eb6b86aaf5f5abf 0e0415e41f9edb5fa9f148b69fbdf588 1aad5737520e855c111c4649594ab070 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da Universidade Federal de Alfenas - RiUnifal - Universidade Federal de Alfenas (UNIFAL) |
| repository.mail.fl_str_mv |
repositorio@unifal-mg.edu.br |
| _version_ |
1859830870575153152 |